Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2003-06-27
2009-06-30
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S141000
Reexamination Certificate
active
07553852
ABSTRACT:
The present invention relates to compounds of formula I:useful as inhibitors of caspases. The present invention also provides pharmaceutically acceptable compositions comprising said compounds, processes for preparing the compounds, and methods of using the compounds and compositions in the treatment of various diseases, conditions, or disorders.
REFERENCES:
patent: 4728647 (1988-03-01), Benavides et al.
patent: 5656627 (1997-08-01), Bemis et al.
patent: 5716929 (1998-02-01), Bemis et al.
patent: 5756466 (1998-05-01), Bemis et al.
patent: 5847135 (1998-12-01), Bemis et al.
patent: 5973111 (1999-10-01), Bemis et al.
patent: 6025147 (2000-02-01), Bemis et al.
patent: 6103711 (2000-08-01), Bemis et al.
patent: 6420522 (2002-07-01), Bemis et al.
patent: 6525076 (2003-02-01), Zhu et al.
patent: 2003/0162993 (2003-08-01), Mortimore et al.
patent: 2004/0019017 (2004-01-01), Mortimore et al.
patent: 2004/0048797 (2004-03-01), Miller et al.
patent: 2004/0242494 (2004-12-01), Brenchley et al.
patent: 232 699 (1986-02-01), None
patent: 07/61680 (1997-12-01), None
patent: 1203766 (2002-05-01), None
patent: WO 95/35308 (1995-12-01), None
patent: WO 96/40647 (1996-12-01), None
patent: WO 97/22619 (1997-06-01), None
patent: WO 98/16502 (1998-04-01), None
patent: WO 98/16505 (1998-04-01), None
patent: 98/18781 (1998-05-01), None
patent: 00/67746 (2000-11-01), None
patent: WO 00/68188 (2000-11-01), None
patent: WO 01/42216 (2001-06-01), None
patent: WO 01/42216 (2001-06-01), None
patent: 01/94351 (2001-12-01), None
patent: WO 03/068242 (2003-08-01), None
patent: 2004/002961 (2004-01-01), None
patent: WO 2004/58718 (2004-07-01), None
patent: WO 2006/057961 (2006-06-01), None
Semple, G., et al. “Pyridone-Based Peptidomimetic Inhibitors of Interleukin-1β-Converting Enzyme (ICE),”Bioorganic&Medicinal Chem. Letters, 7(10):1337-1342 (1997).
Livingston, D.J. “In Vitro and In Vivo Studies of Ice Inhibitors,”J. of Cell. Biochem., 64(1):19-26 (1997).
Husain, M. I., et al. “Some New 2-Aryloxymethyl-3-alpha-substituted Carboxymethyl-6,8-substituted-4-Quinazolones As Possible Anticonvulsants,”,Pharmazie, 37(6):408-410 (1982).
Hussain, M., Imtiaz, et al. “Some Newer Quinazolones as Possible Anticonvulsants,”J. Chem. Soc. Pak, 6(4):211-215 (1984).
Canonne, P., et al. “Synthesis of chiral 3-substituted 2,4(1H,3H)-quinazolinediones,”Heterocycles, 36(6):1305-1314 (1993).
Gouilleux, L, et al., “Solid Phase Synthesis of Chiral 3-substituted Quinazoline-2, 4-diones,”Tetrahedron, Letters, 37(39):7031-7034 (1996).
Gordeev, M.F., et al. “A General and Efficient Solid Phase Synthesis of Quinazoline-2, 4-diones,”Tetrahedron Letters, 38(10):1729-1732 (1997).
Prokai-Tatrai, K., et al., “Prodrugs to Enhance Central Nervous System Effects of TRH-like Peptide pGlu-Glu-Pro-NH2,” Bioorg. Med. Chem. Lett., 13:1011-1014 (2003).
Narasimhan, R. S., “Synthetic Application of Lithiation Reactions; IX. A Simplified Synthesis of Isocoumarin,” Synthesis, 12: 797 (1975).
Kinder, M. A., et al., “Solid State Photochemistry of Isocoumarins and Isothiocoumarins,” Tetrahedron 56: 6763-6767 (2000).
Revesz, L., et al., “Synthesis of P1 Aspartate-Based Peptide Acyloxymethyl and Fluoromethyl Ketones as Inhibitors of Interleukin-1β-Converting Enzyme,” Tetrahedron Letters, 35 (52) :9693-9696 (1994).
Aug. 31, 2005 Office Action from U.S. Appl. No. 10/743,563.
Oct. 3, 2006 Office Action from U.S. Appl. No. 10/743,563.
Jul. 9, 2007 Examiner's Amendment from U.S. Appl. No. 10/743,563.
Jun. 12, 2003 Office Action from U.S. Appl. No. 10/166,437.
Feb. 26, 2004 Office Action from U.S. Appl. No. 10/166,437.
Jan. 26, 2007 Office Action from U.S. Appl. No. 10/166,437.
Golec, et al., “Structure-Based Design of Non-Peptidic Pyridone Aldehydes as Inhibitors of Interleukin-1β Converting Enzyme”, Bioorganic & Medicinal Chemistry Letters (1997), vol. 7, No. 17, pp. 2181-2186.
Semple, et al., “Peptidomimetic Aminomethylene Ketone Inhibitors of Interleukin-1β-Converting Enzyme (ICE)”, Bioorganic & Medicinal Chemistry Letters (1998), vol. 8, pp. 959-964.
Knegtel Ronald
Millan David
Mortimore Michael
Studley John
Che Jennifer G.
Dixon Lisa A.
Vertex Pharmaceuticals Incorporated
Ward Paul V.
Wilson James O.
LandOfFree
Caspase inhibitors and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Caspase inhibitors and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Caspase inhibitors and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4097108